Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Sidney A. Schechet (ORCID: https://orcid.org/0000-0001-8996-3855)
- Ella H. Leung (ORCID: https://orcid.org/0000-0002-4874-2471)
- Byron Ladd (ORCID: https://orcid.org/0000-0002-1450-2963)
- Jeffrey S. Heier (ORCID: https://orcid.org/0000-0003-4625-3145)
- Nancy M. Holekamp (ORCID: https://orcid.org/0000-0001-7850-8515)
- Miguel Busquets (ORCID: https://orcid.org/0000-0001-9522-8486)
- Gidi Benyamini (ORCID: https://orcid.org/0000-0003-4496-8462)
- Eric W. Schneider (ORCID: https://orcid.org/0000-0002-8784-7524)
- Kester Nahen (ORCID: https://orcid.org/0009-0000-3271-8250)
- Michael J. Elman (ORCID: https://orcid.org/0000-0001-7726-9508)
- Kapil Kapoor (ORCID: https://orcid.org/0000-0001-5622-225X)
- Nishant Mohan
- Ron Danis
Institutions
- Meriter Hospital (US)
- Elman Retina Group (US)
- Retina Associates of Kentucky (US)
- Jones Institute (US)
- Lifelong Vision Foundation (US)
- Ophthalmic Consultants of Boston (US)
- Virginia Eye Consultants (US)
- Applied Visions (United States) (US)
- Tennessee Retina (US)
Publication Details
- Journal
- Ophthalmology Science
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1016/j.xops.2025.100772
- Citations
- 7
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 11.95